NKGen Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NKGen Biotech and buy or sell other stocks, ETFs, and their options commission-free!About NKGN
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression.
CEOPaul Y. Song
CEOPaul Y. Song
Employees26
Employees26
HeadquartersSanta Ana, California
HeadquartersSanta Ana, California
Founded2017
Founded2017
Employees26
Employees26
NKGN Key Statistics
Market cap4.60M
Market cap4.60M
Price-Earnings ratio-0.03
Price-Earnings ratio-0.03
Dividend yield—
Dividend yield—
Average volume6.47K
Average volume6.47K
High today$0.037
High today$0.037
Low today$0.037
Low today$0.037
Open price$0.037
Open price$0.037
Volume2.02K
Volume2.02K
52 Week high$0.9649
52 Week high$0.9649
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
As of today, NKGen Biotech(NKGN) shares are valued at $0.04. The company's market cap stands at 4.6M, with a P/E ratio of -0.03.
As of 2025-12-10, NKGen Biotech(NKGN) stock has fluctuated between $0.04 and $0.04. The current price stands at $0.04, placing the stock 0.0% above today's low and 0.0% off the high.
NKGen Biotech(NKGN) shares are trading with a volume of 2.02K, against a daily average of 6.47K.
In the last year, NKGen Biotech(NKGN) shares hit a 52-week high of $0.96 and a 52-week low of $0.00.
In the last year, NKGen Biotech(NKGN) shares hit a 52-week high of $0.96 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own NKGN. This list is generated using Robinhood data, and it’s not a recommendation.